Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is a 500 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $8.057 million which beat the analyst consensus estimate of $7.547 million by 6.75 percent. This is a 13.50 percent decrease over sales of $9.314 million the same period last year.